NDC 73309-207 - Ondansetron HCl dihydrate

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
73309-207
Package NDCs from labels
73309-207-01, 73309-207-02
Manufacturer
BLUEBAY SHANDONG CO.,LTD
Effective date
2021-10-21
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Ondansetron HCl dihydrate - BLUEBAY SHANDONG CO.,LTDBLUEBAY SHANDONG CO.,LTD2021-10-21BULK INGREDIENT

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73309-207-01Ondansetron HCl dihydrate250 g in 1 JARPOWDER2502
73309-207-02Ondansetron HCl dihydrate25 g in 1 JARPOWDER252

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73309-207ONDANSETRON HCL DIHYDRATE POWDER [BLUEBAY SHANDONG CO.,LTD]22 package rows20211023_32ae28af-2b8a-4c5c-90da-b4723f65f899.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 7 · 139 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ondansetron HydrochlorideONDANSETRON HYDROCHLORIDEA-S Medication Solutionse0f69f57-aeb9-4890-85aa-e5976208e8be2026-02-12Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
OndansetronONDANSETRONGolden State Medical Supply, Inc.2b9ea1fc-59a4-8189-e063-6394a90a9ae62026-01-27Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
OndansetronONDANSETRONPD-Rx Pharmaceuticals, Inc.15d0a711-ef3b-4d93-8fbc-17a45f96af8a2026-01-20Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
ONDANSETRON HYDROCHLORIDEONDANSETRON HYDROCHLORIDECardinal Health 107, LLC30107d6f-5128-484f-b713-65244a98dc672026-01-14Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
OndansetronONDANSETRONAvPAK05cf8d4f-ac57-4177-e063-6394a90ae8042026-01-09Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
OndansetronONDANSETRONGlenmark Pharmaceuticals Inc., USAeee5217a-eba8-463a-812d-bf3c66f0934f2026-01-08Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
Ondansetron HydrochlorideONDANSETRON HYDROCHLORIDEChartwell Governmental & Specialty RX, LLC.7e862601-1d8a-455b-8ce5-1a32478b309f2026-01-07Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
Ondansetron HydrochlorideONDANSETRON HYDROCHLORIDEChartwell RX, LLC.2086bae8-7c3c-4663-93ac-c86407c524c22026-01-02Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
Ondansetron HydrochlorideONDANSETRON HYDROCHLORIDENorthwind Health Company, LLCf76d27c5-acd4-482c-e053-6294a90a52842026-01-01Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
Ondansetron HydrochlorideONDANSETRON HYDROCHLORIDENorthwind Health Company, LLCf29f8ae1-4826-d8eb-e053-2a95a90a691a2026-01-01Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
Ondansetron HydrochlorideONDANSETRON HYDROCHLORIDENorthwind Health Company, LLC852a3251-bf28-5557-e053-2991aa0a4fbd2026-01-01Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
Ondansetron HydrochlorideONDANSETRON HYDROCHLORIDENorthwind Health Company, LLCdb99c77a-0b01-9da6-e053-2a95a90a51992026-01-01Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
OndansetronONDANSETRONRedpharm Drug300b1916-a3d8-0220-e063-6394a90a6f552025-12-23Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
OndansetronONDANSETRONNatco Pharma USA LLC64527de5-0b92-4340-9243-7a37e8ff96d92025-12-19Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
Ondansetron HydrochlorideONDANSETRON HYDROCHLORIDEQPharma, Inc.fbe71308-2927-2467-e053-6394a90aa4192025-12-16Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
Ondansetron HydrochlorideONDANSETRON HYDROCHLORIDEQPharma, Inc.2fa30bdb-f60e-40a7-98b4-c346bc85d5392025-12-15Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
Ondansetron HydrochlorideONDANSETRON HYDROCHLORIDEQPharma, Inc.dafe875e-391f-47a2-97b7-89840a760e442025-12-15Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
OndansetronONDANSETRONHospira, Inc.e0862c02-781f-4b10-ae50-9c9c4ca26f6d2025-12-01Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
ondansetron hydrochlorideONDANSETRON HYDROCHLORIDEOnesource Specialty Pharma Limited438c3d28-8bed-50f0-e063-6394a90a18e42025-11-14Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B
ondansetron hydrochlorideONDANSETRON HYDROCHLORIDEOnesource Specialty Pharma Limiteda5fe05bc-a7a5-4131-8c4d-2edd113441ec2025-11-14Warnings, Adverse reactionsExact identifier
unii: NMH84OZK2B

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.